Healthcare data should be accurate, accessible, and timely.
Leveraging the deep expertise of a prominent oncologist and the technical expertise of leading engineers, our software quickly and accurately converts unstructured data into structured data. It creates the codes and fields you need populated for reports and forms across your organization, saving significant processing time, increasing throughput, and reducing costs throughout your institution.
What can NeuralFrame do for you?
- Timely registry submissions
- Case identification
- Accurate invoicing
- Co-morbidity identification
Features to Improve your Workflow
Our software provides a feature-rich, modern experience that employs true statistical learning, validation, and feedback.
Automated Data Extraction
Expert clinician-trained AI identifies and extracts pertinent content
Supporting Evidence Presentation
Outputs are directly supported and linked to specific, identifiable content
Improved Data Accuracy
Keystroke and reasoning errors are virtually eliminated.
Intuitive User Interface
Easy to understand system requires minimal training time.
For HIPAA Compliance
The most advanced encryption technology and best practices in place for patient privacy.
Leveraging the AWS Cloud, our software can be accessed virtually anywhere in the world.
We're on a mission to introduce a new wave of medical insight.
Founded in 2017, NeuralFrame has developed our software to be the gold standard for oncology concurrent coding. Our team of expert physicians and leading engineers believe faster processing with more insight means a higher quality healthcare system. That doesn’t just save time, it saves lives.
As a gold member with HL7® (Health Level 7 International), NeuralFrame is helping to make interoperability a reality.
FHIR® and the FLAME mark are the registered trademarks of HL7 and are used with the permission of HL7. The use of these trademarks do not constitute a product endorsement by HL7.
A sustaining member of NAACCR, NeuralFrame supports its missions including the goal of reducing the burden of cancer in North America.